Navigating Together for a Better Tomorrow
How Quasar Is Responding to COVID-19 and Its Effect On Businesses
As the coronavirus pandemic continues to change the world, we’re all navigating through uncertainty.
At Quasar, we embrace our “philosophy of operational excellence”. This means that even in times of struggle, we have an operational focused effort. While our number one concern is the health and safety of our employees and our community, we are also here to assist you with business continuity, even in these uncertain times.
How We're Helping
Meeting all Q-2 commitments and more.
We are here to support the medical device companies globally who have been affected by the pandemic and thus facing challenges to meet previously set production goals. To ensure we are in a position to to support your production needs, we have EXPANDED Manufacturing Capacity in the following areas:
ISO/FDA Registered Facilities
+30k sqft ISO 7/8 Clean Rooms at our ISO/FDA Registered Facilities in China, Hong Kong, and Thailand.
with additional capacity to support Class II & III devices.
Critical Backorders recovery plan
Commercial and Manufacturing teams at the ready to assist with evaluating and developing a recovery plan for you.
Commercial, Quality and Supply Chain teams at the ready to assist with your supplier qualification and approval process to qualify a second source.
Commercial, Quality and Engineering teams at the ready to assist with validation and transfer plans to support a manufacturing transfer project.
Emergency Action Plans
Quasar can assist with developing an emergency (mitigation) action plan to avoid future disruptions to your supply chain.
Embolization coiling is a minimally invasive catheter-based procedure that employs a coil that can cause an occlusion. What’s important is that the design is made easy to handle and produces the desired effect at the intended location.
The new MAH or Marketing Authorization Holder Policy has opened up a whole new level of opportunities for medical device companies. OEMs must capitalize on the major changes taking place in the Chinese market in allowing high-quality medical devices to be manufactured and marketed without as many restrictions as they experienced prior to the MAH Policy.
If these core elements are not carefully assessed, planned and tested through prototyping, the problems arising at the FDA approval stage, production stage and usage with the end-users will negate profitability
Embolization coiling is a minimally invasive catheter-based procedure that employs a coil that can cause an occlusion. What’s important... read more
The new MAH or Marketing Authorization Holder Policy has opened up a whole new level of opportunities for medical... read more
If these core elements are not carefully assessed, planned and tested through prototyping, the problems arising at the FDA... read more